Source: Memórias do Instituto Oswaldo Cruz. Unidade: FMRP
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN NETO, Jose Antonio et al. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Memórias do Instituto Oswaldo Cruz, v. 104, p. 319-324, 2009Tradução . . Disponível em: https://doi.org/10.1590/s0074-02762009000900042. Acesso em: 21 maio 2024.APA
Marin Neto, J. A., Rassi Junior, A., Avezum Júnior, Á., Mattos, A. C., & Rassi, A. (2009). The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Memórias do Instituto Oswaldo Cruz, 104, 319-324. doi:10.1590/s0074-02762009000900042NLM
Marin Neto JA, Rassi Junior A, Avezum Júnior Á, Mattos AC, Rassi A. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease [Internet]. Memórias do Instituto Oswaldo Cruz. 2009 ; 104 319-324.[citado 2024 maio 21 ] Available from: https://doi.org/10.1590/s0074-02762009000900042Vancouver
Marin Neto JA, Rassi Junior A, Avezum Júnior Á, Mattos AC, Rassi A. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease [Internet]. Memórias do Instituto Oswaldo Cruz. 2009 ; 104 319-324.[citado 2024 maio 21 ] Available from: https://doi.org/10.1590/s0074-02762009000900042
